nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—hypertension—obesity	0.321	1	CtDrD
Labetalol—ADRB3—obesity	0.135	0.546	CbGaD
Labetalol—Isoxsuprine—Phenylpropanolamine—obesity	0.0788	0.458	CrCrCtD
Labetalol—ADRB1—obesity	0.0609	0.247	CbGaD
Labetalol—Lisdexamfetamine—Methamphetamine—obesity	0.0597	0.347	CrCrCtD
Labetalol—ADRB2—Phenylpropanolamine—obesity	0.0565	0.352	CbGbCtD
Labetalol—ADRB1—Phenylpropanolamine—obesity	0.0556	0.346	CbGbCtD
Labetalol—ADRB2—obesity	0.0512	0.208	CbGaD
Labetalol—Propafenone—Benzphetamine—obesity	0.0335	0.195	CrCrCtD
Labetalol—CYP2D6—Phentermine—obesity	0.0149	0.0924	CbGbCtD
Labetalol—CYP2D6—Bupropion—obesity	0.0126	0.0786	CbGbCtD
Labetalol—CYP2D6—Methamphetamine—obesity	0.0119	0.0739	CbGbCtD
Labetalol—CYP2D6—Cimetidine—obesity	0.00927	0.0577	CbGbCtD
Labetalol—ADRB3—brown adipose tissue—obesity	0.00423	0.704	CbGeAlD
Labetalol—ADRB3—adipose tissue—obesity	0.000571	0.0951	CbGeAlD
Labetalol—ADRB1—cardiovascular system—obesity	0.000265	0.0441	CbGeAlD
Labetalol—CYP2D6—hindbrain—obesity	0.000263	0.0439	CbGeAlD
Labetalol—ADRB1—adipose tissue—obesity	0.000233	0.0389	CbGeAlD
Labetalol—Isoprenaline—PIK3R1—obesity	0.000221	0.101	CrCbGaD
Labetalol—Mirabegron—ADRB3—obesity	0.000186	0.085	CrCbGaD
Labetalol—ADRB1—endocrine gland—obesity	0.000181	0.0302	CbGeAlD
Labetalol—Fenoterol—ADRB3—obesity	0.000163	0.0749	CrCbGaD
Labetalol—Arbutamine—ADRB3—obesity	0.000153	0.07	CrCbGaD
Labetalol—Mood swings—Bupropion—obesity	0.000126	0.00224	CcSEcCtD
Labetalol—Somnolence—Cimetidine—obesity	0.000125	0.00222	CcSEcCtD
Labetalol—Dysuria—Sibutramine—obesity	0.000124	0.00219	CcSEcCtD
Labetalol—Nausea—Phendimetrazine—obesity	0.000124	0.00219	CcSEcCtD
Labetalol—Asthenia—Phentermine—obesity	0.000122	0.00216	CcSEcCtD
Labetalol—Feeling abnormal—Diethylpropion—obesity	0.000122	0.00216	CcSEcCtD
Labetalol—Orthostatic hypotension—Bupropion—obesity	0.000122	0.00216	CcSEcCtD
Labetalol—Abdominal pain upper—Bupropion—obesity	0.000122	0.00216	CcSEcCtD
Labetalol—Erectile dysfunction—Sibutramine—obesity	0.000122	0.00216	CcSEcCtD
Labetalol—Depression—Orlistat—obesity	0.000121	0.00215	CcSEcCtD
Labetalol—Fatigue—Cimetidine—obesity	0.000121	0.00215	CcSEcCtD
Labetalol—Atrioventricular block—Topiramate—obesity	0.000121	0.00214	CcSEcCtD
Labetalol—Constipation—Cimetidine—obesity	0.00012	0.00213	CcSEcCtD
Labetalol—Cramp muscle—Bupropion—obesity	0.00012	0.00213	CcSEcCtD
Labetalol—Depression—Sibutramine—obesity	0.000118	0.00208	CcSEcCtD
Labetalol—Urticaria—Diethylpropion—obesity	0.000117	0.00208	CcSEcCtD
Labetalol—Dizziness—Phenylpropanolamine—obesity	0.000117	0.00208	CcSEcCtD
Labetalol—Diarrhoea—Phentermine—obesity	0.000116	0.00206	CcSEcCtD
Labetalol—Feeling abnormal—Cimetidine—obesity	0.000116	0.00206	CcSEcCtD
Labetalol—Bronchospasm—Bupropion—obesity	0.000113	0.00201	CcSEcCtD
Labetalol—Sweating—Sibutramine—obesity	0.000113	0.002	CcSEcCtD
Labetalol—Vomiting—Phenylpropanolamine—obesity	0.000113	0.002	CcSEcCtD
Labetalol—Dizziness—Phentermine—obesity	0.000112	0.00199	CcSEcCtD
Labetalol—Sweating increased—Bupropion—obesity	0.000112	0.00199	CcSEcCtD
Labetalol—Rash—Phenylpropanolamine—obesity	0.000112	0.00199	CcSEcCtD
Labetalol—Dermatitis—Phenylpropanolamine—obesity	0.000112	0.00198	CcSEcCtD
Labetalol—Body temperature increased—Cimetidine—obesity	0.000111	0.00197	CcSEcCtD
Labetalol—Epistaxis—Sibutramine—obesity	0.000111	0.00197	CcSEcCtD
Labetalol—Hepatitis—Orlistat—obesity	0.000109	0.00194	CcSEcCtD
Labetalol—Dry eye—Topiramate—obesity	0.000108	0.00192	CcSEcCtD
Labetalol—Vomiting—Phentermine—obesity	0.000108	0.00192	CcSEcCtD
Labetalol—Dysuria—Bupropion—obesity	0.000108	0.00191	CcSEcCtD
Labetalol—Bradycardia—Sibutramine—obesity	0.000108	0.00191	CcSEcCtD
Labetalol—Oedema peripheral—Orlistat—obesity	0.000108	0.00191	CcSEcCtD
Labetalol—Rash—Phentermine—obesity	0.000107	0.0019	CcSEcCtD
Labetalol—Dermatitis—Phentermine—obesity	0.000107	0.0019	CcSEcCtD
Labetalol—Headache—Phentermine—obesity	0.000107	0.00189	CcSEcCtD
Labetalol—Erectile dysfunction—Bupropion—obesity	0.000106	0.00188	CcSEcCtD
Labetalol—Nausea—Phenylpropanolamine—obesity	0.000106	0.00187	CcSEcCtD
Labetalol—Hypoaesthesia—Sibutramine—obesity	0.000105	0.00187	CcSEcCtD
Labetalol—Oedema peripheral—Sibutramine—obesity	0.000104	0.00185	CcSEcCtD
Labetalol—Hypersensitivity—Cimetidine—obesity	0.000104	0.00184	CcSEcCtD
Labetalol—CYP2D6—digestive system—obesity	0.000102	0.017	CbGeAlD
Labetalol—Visual impairment—Sibutramine—obesity	0.000102	0.00181	CcSEcCtD
Labetalol—Diarrhoea—Diethylpropion—obesity	0.000101	0.00179	CcSEcCtD
Labetalol—Nausea—Phentermine—obesity	0.000101	0.00179	CcSEcCtD
Labetalol—Asthenia—Cimetidine—obesity	0.000101	0.00179	CcSEcCtD
Labetalol—Jaundice—Bupropion—obesity	0.0001	0.00178	CcSEcCtD
Labetalol—Dobutamine—COMT—obesity	9.99e-05	0.0458	CrCbGaD
Labetalol—Sweating—Bupropion—obesity	9.85e-05	0.00175	CcSEcCtD
Labetalol—Sleep disorder—Topiramate—obesity	9.82e-05	0.00174	CcSEcCtD
Labetalol—Dizziness—Diethylpropion—obesity	9.78e-05	0.00173	CcSEcCtD
Labetalol—Epistaxis—Bupropion—obesity	9.69e-05	0.00172	CcSEcCtD
Labetalol—Alopecia—Orlistat—obesity	9.66e-05	0.00171	CcSEcCtD
Labetalol—Diarrhoea—Cimetidine—obesity	9.63e-05	0.00171	CcSEcCtD
Labetalol—Mental disorder—Orlistat—obesity	9.58e-05	0.0017	CcSEcCtD
Labetalol—Disorientation—Topiramate—obesity	9.5e-05	0.00168	CcSEcCtD
Labetalol—Vomiting—Diethylpropion—obesity	9.4e-05	0.00167	CcSEcCtD
Labetalol—Alopecia—Sibutramine—obesity	9.35e-05	0.00166	CcSEcCtD
Labetalol—Nasal congestion—Topiramate—obesity	9.33e-05	0.00165	CcSEcCtD
Labetalol—Rash—Diethylpropion—obesity	9.32e-05	0.00165	CcSEcCtD
Labetalol—Dermatitis—Diethylpropion—obesity	9.32e-05	0.00165	CcSEcCtD
Labetalol—Dizziness—Cimetidine—obesity	9.31e-05	0.00165	CcSEcCtD
Labetalol—Headache—Diethylpropion—obesity	9.27e-05	0.00164	CcSEcCtD
Labetalol—Hepatitis—Bupropion—obesity	9.23e-05	0.00164	CcSEcCtD
Labetalol—Hypoaesthesia—Bupropion—obesity	9.18e-05	0.00163	CcSEcCtD
Labetalol—Hallucination—Bupropion—obesity	9.18e-05	0.00163	CcSEcCtD
Labetalol—Muscle spasms—Orlistat—obesity	9.15e-05	0.00162	CcSEcCtD
Labetalol—Oedema peripheral—Bupropion—obesity	9.09e-05	0.00161	CcSEcCtD
Labetalol—Amnesia—Topiramate—obesity	9.04e-05	0.0016	CcSEcCtD
Labetalol—Vision blurred—Orlistat—obesity	8.97e-05	0.00159	CcSEcCtD
Labetalol—Vomiting—Cimetidine—obesity	8.95e-05	0.00159	CcSEcCtD
Labetalol—Visual impairment—Bupropion—obesity	8.89e-05	0.00158	CcSEcCtD
Labetalol—Rash—Cimetidine—obesity	8.87e-05	0.00157	CcSEcCtD
Labetalol—Dermatitis—Cimetidine—obesity	8.86e-05	0.00157	CcSEcCtD
Labetalol—Muscle spasms—Sibutramine—obesity	8.86e-05	0.00157	CcSEcCtD
Labetalol—Ill-defined disorder—Orlistat—obesity	8.83e-05	0.00157	CcSEcCtD
Labetalol—Headache—Cimetidine—obesity	8.82e-05	0.00156	CcSEcCtD
Labetalol—Nausea—Diethylpropion—obesity	8.78e-05	0.00156	CcSEcCtD
Labetalol—Hypoglycaemia—Topiramate—obesity	8.71e-05	0.00154	CcSEcCtD
Labetalol—Angioedema—Orlistat—obesity	8.7e-05	0.00154	CcSEcCtD
Labetalol—Vision blurred—Sibutramine—obesity	8.68e-05	0.00154	CcSEcCtD
Labetalol—Lethargy—Topiramate—obesity	8.67e-05	0.00154	CcSEcCtD
Labetalol—Tremor—Sibutramine—obesity	8.63e-05	0.00153	CcSEcCtD
Labetalol—Malaise—Orlistat—obesity	8.58e-05	0.00152	CcSEcCtD
Labetalol—Flushing—Bupropion—obesity	8.56e-05	0.00152	CcSEcCtD
Labetalol—Vertigo—Orlistat—obesity	8.55e-05	0.00152	CcSEcCtD
Labetalol—Ill-defined disorder—Sibutramine—obesity	8.55e-05	0.00151	CcSEcCtD
Labetalol—CYP2D6—endocrine gland—obesity	8.45e-05	0.0141	CbGeAlD
Labetalol—Angioedema—Sibutramine—obesity	8.42e-05	0.00149	CcSEcCtD
Labetalol—Palpitations—Orlistat—obesity	8.41e-05	0.00149	CcSEcCtD
Labetalol—Affect lability—Topiramate—obesity	8.36e-05	0.00148	CcSEcCtD
Labetalol—Nausea—Cimetidine—obesity	8.36e-05	0.00148	CcSEcCtD
Labetalol—Malaise—Sibutramine—obesity	8.31e-05	0.00147	CcSEcCtD
Labetalol—Psychotic disorder—Topiramate—obesity	8.3e-05	0.00147	CcSEcCtD
Labetalol—Vertigo—Sibutramine—obesity	8.28e-05	0.00147	CcSEcCtD
Labetalol—Syncope—Sibutramine—obesity	8.26e-05	0.00146	CcSEcCtD
Labetalol—Mirabegron—BCHE—obesity	8.21e-05	0.0376	CrCbGaD
Labetalol—Alopecia—Bupropion—obesity	8.15e-05	0.00144	CcSEcCtD
Labetalol—Palpitations—Sibutramine—obesity	8.14e-05	0.00144	CcSEcCtD
Labetalol—Loss of consciousness—Sibutramine—obesity	8.1e-05	0.00143	CcSEcCtD
Labetalol—Mental disorder—Bupropion—obesity	8.08e-05	0.00143	CcSEcCtD
Labetalol—Urinary retention—Topiramate—obesity	8.08e-05	0.00143	CcSEcCtD
Labetalol—Mood swings—Topiramate—obesity	8.05e-05	0.00143	CcSEcCtD
Labetalol—Discomfort—Orlistat—obesity	8.01e-05	0.00142	CcSEcCtD
Labetalol—Isoprenaline—ADRB3—obesity	7.98e-05	0.0366	CrCbGaD
Labetalol—Hypertension—Sibutramine—obesity	7.95e-05	0.00141	CcSEcCtD
Labetalol—Liver function test abnormal—Topiramate—obesity	7.84e-05	0.00139	CcSEcCtD
Labetalol—Anaphylactic shock—Orlistat—obesity	7.77e-05	0.00138	CcSEcCtD
Labetalol—Oedema—Orlistat—obesity	7.77e-05	0.00138	CcSEcCtD
Labetalol—Orthostatic hypotension—Topiramate—obesity	7.76e-05	0.00138	CcSEcCtD
Labetalol—Abdominal pain upper—Topiramate—obesity	7.76e-05	0.00138	CcSEcCtD
Labetalol—Discomfort—Sibutramine—obesity	7.75e-05	0.00137	CcSEcCtD
Labetalol—Muscle spasms—Bupropion—obesity	7.72e-05	0.00137	CcSEcCtD
Labetalol—CYP2D6—liver—obesity	7.62e-05	0.0127	CbGeAlD
Labetalol—Confusional state—Sibutramine—obesity	7.58e-05	0.00134	CcSEcCtD
Labetalol—Vision blurred—Bupropion—obesity	7.57e-05	0.00134	CcSEcCtD
Labetalol—Tremor—Bupropion—obesity	7.52e-05	0.00133	CcSEcCtD
Labetalol—Oedema—Sibutramine—obesity	7.52e-05	0.00133	CcSEcCtD
Labetalol—Anaphylactic shock—Sibutramine—obesity	7.52e-05	0.00133	CcSEcCtD
Labetalol—Hyperhidrosis—Orlistat—obesity	7.51e-05	0.00133	CcSEcCtD
Labetalol—Ill-defined disorder—Bupropion—obesity	7.45e-05	0.00132	CcSEcCtD
Labetalol—Shock—Sibutramine—obesity	7.4e-05	0.00131	CcSEcCtD
Labetalol—Fenoterol—ADRB1—obesity	7.39e-05	0.0338	CrCbGaD
Labetalol—Angioedema—Bupropion—obesity	7.34e-05	0.0013	CcSEcCtD
Labetalol—Hyperhidrosis—Sibutramine—obesity	7.27e-05	0.00129	CcSEcCtD
Labetalol—Malaise—Bupropion—obesity	7.24e-05	0.00128	CcSEcCtD
Labetalol—Vertigo—Bupropion—obesity	7.22e-05	0.00128	CcSEcCtD
Labetalol—Syncope—Bupropion—obesity	7.2e-05	0.00128	CcSEcCtD
Labetalol—Angina pectoris—Topiramate—obesity	7.15e-05	0.00127	CcSEcCtD
Labetalol—Sweating increased—Topiramate—obesity	7.15e-05	0.00127	CcSEcCtD
Labetalol—Palpitations—Bupropion—obesity	7.1e-05	0.00126	CcSEcCtD
Labetalol—Loss of consciousness—Bupropion—obesity	7.06e-05	0.00125	CcSEcCtD
Labetalol—Hypotension—Sibutramine—obesity	7.03e-05	0.00125	CcSEcCtD
Labetalol—Paraesthesia—Orlistat—obesity	6.98e-05	0.00124	CcSEcCtD
Labetalol—Hypertension—Bupropion—obesity	6.93e-05	0.00123	CcSEcCtD
Labetalol—Arbutamine—ADRB1—obesity	6.91e-05	0.0317	CrCbGaD
Labetalol—Dysuria—Topiramate—obesity	6.87e-05	0.00122	CcSEcCtD
Labetalol—Dyspepsia—Orlistat—obesity	6.84e-05	0.00121	CcSEcCtD
Labetalol—Erectile dysfunction—Topiramate—obesity	6.76e-05	0.0012	CcSEcCtD
Labetalol—Discomfort—Bupropion—obesity	6.76e-05	0.0012	CcSEcCtD
Labetalol—Paraesthesia—Sibutramine—obesity	6.75e-05	0.0012	CcSEcCtD
Labetalol—Arformoterol—ADRB1—obesity	6.71e-05	0.0307	CrCbGaD
Labetalol—Formoterol—ADRB1—obesity	6.71e-05	0.0307	CrCbGaD
Labetalol—Dyspnoea—Sibutramine—obesity	6.7e-05	0.00119	CcSEcCtD
Labetalol—Fatigue—Orlistat—obesity	6.7e-05	0.00119	CcSEcCtD
Labetalol—Somnolence—Sibutramine—obesity	6.68e-05	0.00118	CcSEcCtD
Labetalol—Benazepril—MTHFR—obesity	6.66e-05	0.0305	CrCbGaD
Labetalol—Pain—Orlistat—obesity	6.64e-05	0.00118	CcSEcCtD
Labetalol—Dyspepsia—Sibutramine—obesity	6.62e-05	0.00117	CcSEcCtD
Labetalol—Confusional state—Bupropion—obesity	6.61e-05	0.00117	CcSEcCtD
Labetalol—Anaphylactic shock—Bupropion—obesity	6.55e-05	0.00116	CcSEcCtD
Labetalol—Oedema—Bupropion—obesity	6.55e-05	0.00116	CcSEcCtD
Labetalol—Depression—Topiramate—obesity	6.53e-05	0.00116	CcSEcCtD
Labetalol—Salmeterol—ADRB2—obesity	6.46e-05	0.0296	CrCbGaD
Labetalol—Shock—Bupropion—obesity	6.45e-05	0.00114	CcSEcCtD
Labetalol—Pain—Sibutramine—obesity	6.43e-05	0.00114	CcSEcCtD
Labetalol—Constipation—Sibutramine—obesity	6.43e-05	0.00114	CcSEcCtD
Labetalol—Feeling abnormal—Orlistat—obesity	6.4e-05	0.00113	CcSEcCtD
Labetalol—Dobutamine—ADRB1—obesity	6.36e-05	0.0291	CrCbGaD
Labetalol—Gastrointestinal pain—Orlistat—obesity	6.35e-05	0.00113	CcSEcCtD
Labetalol—Hyperhidrosis—Bupropion—obesity	6.34e-05	0.00112	CcSEcCtD
Labetalol—Quinapril—ACE—obesity	6.24e-05	0.0286	CrCbGaD
Labetalol—Fenoterol—ADRB2—obesity	6.22e-05	0.0285	CrCbGaD
Labetalol—Ritodrine—ADRB2—obesity	6.22e-05	0.0285	CrCbGaD
Labetalol—Feeling abnormal—Sibutramine—obesity	6.2e-05	0.0011	CcSEcCtD
Labetalol—Epistaxis—Topiramate—obesity	6.18e-05	0.00109	CcSEcCtD
Labetalol—Urticaria—Orlistat—obesity	6.17e-05	0.00109	CcSEcCtD
Labetalol—Gastrointestinal pain—Sibutramine—obesity	6.15e-05	0.00109	CcSEcCtD
Labetalol—Abdominal pain—Orlistat—obesity	6.14e-05	0.00109	CcSEcCtD
Labetalol—Body temperature increased—Orlistat—obesity	6.14e-05	0.00109	CcSEcCtD
Labetalol—Hypotension—Bupropion—obesity	6.12e-05	0.00109	CcSEcCtD
Labetalol—Agranulocytosis—Topiramate—obesity	6.11e-05	0.00108	CcSEcCtD
Labetalol—Bradycardia—Topiramate—obesity	5.98e-05	0.00106	CcSEcCtD
Labetalol—Urticaria—Sibutramine—obesity	5.97e-05	0.00106	CcSEcCtD
Labetalol—Abdominal pain—Sibutramine—obesity	5.94e-05	0.00105	CcSEcCtD
Labetalol—Body temperature increased—Sibutramine—obesity	5.94e-05	0.00105	CcSEcCtD
Labetalol—Paraesthesia—Bupropion—obesity	5.89e-05	0.00104	CcSEcCtD
Labetalol—Hepatitis—Topiramate—obesity	5.88e-05	0.00104	CcSEcCtD
Labetalol—Hypoaesthesia—Topiramate—obesity	5.85e-05	0.00104	CcSEcCtD
Labetalol—Hallucination—Topiramate—obesity	5.85e-05	0.00104	CcSEcCtD
Labetalol—Dyspnoea—Bupropion—obesity	5.84e-05	0.00104	CcSEcCtD
Labetalol—Somnolence—Bupropion—obesity	5.83e-05	0.00103	CcSEcCtD
Labetalol—Arbutamine—ADRB2—obesity	5.82e-05	0.0266	CrCbGaD
Labetalol—Oedema peripheral—Topiramate—obesity	5.79e-05	0.00103	CcSEcCtD
Labetalol—Dyspepsia—Bupropion—obesity	5.77e-05	0.00102	CcSEcCtD
Labetalol—Hypersensitivity—Orlistat—obesity	5.72e-05	0.00101	CcSEcCtD
Labetalol—Visual impairment—Topiramate—obesity	5.66e-05	0.001	CcSEcCtD
Labetalol—Fatigue—Bupropion—obesity	5.65e-05	0.001	CcSEcCtD
Labetalol—Formoterol—ADRB2—obesity	5.65e-05	0.0258	CrCbGaD
Labetalol—Arformoterol—ADRB2—obesity	5.65e-05	0.0258	CrCbGaD
Labetalol—Constipation—Bupropion—obesity	5.61e-05	0.000993	CcSEcCtD
Labetalol—Pain—Bupropion—obesity	5.61e-05	0.000993	CcSEcCtD
Labetalol—Asthenia—Orlistat—obesity	5.57e-05	0.000988	CcSEcCtD
Labetalol—Hypersensitivity—Sibutramine—obesity	5.54e-05	0.000982	CcSEcCtD
Labetalol—Pruritus—Orlistat—obesity	5.5e-05	0.000974	CcSEcCtD
Labetalol—Flushing—Topiramate—obesity	5.46e-05	0.000967	CcSEcCtD
Labetalol—Benazepril—ACE—obesity	5.43e-05	0.0248	CrCbGaD
Labetalol—Feeling abnormal—Bupropion—obesity	5.4e-05	0.000957	CcSEcCtD
Labetalol—Asthenia—Sibutramine—obesity	5.39e-05	0.000956	CcSEcCtD
Labetalol—Gastrointestinal pain—Bupropion—obesity	5.36e-05	0.00095	CcSEcCtD
Labetalol—Dobutamine—ADRB2—obesity	5.35e-05	0.0245	CrCbGaD
Labetalol—Pruritus—Sibutramine—obesity	5.32e-05	0.000943	CcSEcCtD
Labetalol—Diarrhoea—Orlistat—obesity	5.32e-05	0.000942	CcSEcCtD
Labetalol—Urticaria—Bupropion—obesity	5.21e-05	0.000923	CcSEcCtD
Labetalol—Alopecia—Topiramate—obesity	5.19e-05	0.00092	CcSEcCtD
Labetalol—Body temperature increased—Bupropion—obesity	5.18e-05	0.000918	CcSEcCtD
Labetalol—Abdominal pain—Bupropion—obesity	5.18e-05	0.000918	CcSEcCtD
Labetalol—Mental disorder—Topiramate—obesity	5.15e-05	0.000913	CcSEcCtD
Labetalol—Diarrhoea—Sibutramine—obesity	5.14e-05	0.000912	CcSEcCtD
Labetalol—Dizziness—Orlistat—obesity	5.14e-05	0.00091	CcSEcCtD
Labetalol—Erythema—Topiramate—obesity	5.12e-05	0.000907	CcSEcCtD
Labetalol—Dizziness—Sibutramine—obesity	4.97e-05	0.000881	CcSEcCtD
Labetalol—Vomiting—Orlistat—obesity	4.94e-05	0.000875	CcSEcCtD
Labetalol—Muscle spasms—Topiramate—obesity	4.92e-05	0.000872	CcSEcCtD
Labetalol—Rash—Orlistat—obesity	4.9e-05	0.000868	CcSEcCtD
Labetalol—Dermatitis—Orlistat—obesity	4.89e-05	0.000867	CcSEcCtD
Labetalol—Headache—Orlistat—obesity	4.87e-05	0.000863	CcSEcCtD
Labetalol—Hypersensitivity—Bupropion—obesity	4.83e-05	0.000856	CcSEcCtD
Labetalol—Vision blurred—Topiramate—obesity	4.82e-05	0.000855	CcSEcCtD
Labetalol—Tremor—Topiramate—obesity	4.79e-05	0.00085	CcSEcCtD
Labetalol—Vomiting—Sibutramine—obesity	4.78e-05	0.000847	CcSEcCtD
Labetalol—Ill-defined disorder—Topiramate—obesity	4.75e-05	0.000841	CcSEcCtD
Labetalol—Rash—Sibutramine—obesity	4.74e-05	0.00084	CcSEcCtD
Labetalol—Dermatitis—Sibutramine—obesity	4.74e-05	0.000839	CcSEcCtD
Labetalol—Headache—Sibutramine—obesity	4.71e-05	0.000835	CcSEcCtD
Labetalol—Asthenia—Bupropion—obesity	4.7e-05	0.000833	CcSEcCtD
Labetalol—Pruritus—Bupropion—obesity	4.64e-05	0.000822	CcSEcCtD
Labetalol—Nausea—Orlistat—obesity	4.61e-05	0.000818	CcSEcCtD
Labetalol—Malaise—Topiramate—obesity	4.61e-05	0.000818	CcSEcCtD
Labetalol—Vertigo—Topiramate—obesity	4.6e-05	0.000815	CcSEcCtD
Labetalol—Syncope—Topiramate—obesity	4.59e-05	0.000813	CcSEcCtD
Labetalol—Palpitations—Topiramate—obesity	4.52e-05	0.000801	CcSEcCtD
Labetalol—Loss of consciousness—Topiramate—obesity	4.5e-05	0.000797	CcSEcCtD
Labetalol—Diarrhoea—Bupropion—obesity	4.48e-05	0.000795	CcSEcCtD
Labetalol—Nausea—Sibutramine—obesity	4.47e-05	0.000791	CcSEcCtD
Labetalol—Hypertension—Topiramate—obesity	4.42e-05	0.000783	CcSEcCtD
Labetalol—Dizziness—Bupropion—obesity	4.33e-05	0.000768	CcSEcCtD
Labetalol—Discomfort—Topiramate—obesity	4.3e-05	0.000763	CcSEcCtD
Labetalol—Confusional state—Topiramate—obesity	4.21e-05	0.000746	CcSEcCtD
Labetalol—Oedema—Topiramate—obesity	4.18e-05	0.00074	CcSEcCtD
Labetalol—Vomiting—Bupropion—obesity	4.17e-05	0.000739	CcSEcCtD
Labetalol—Rash—Bupropion—obesity	4.13e-05	0.000732	CcSEcCtD
Labetalol—Dermatitis—Bupropion—obesity	4.13e-05	0.000732	CcSEcCtD
Labetalol—Shock—Topiramate—obesity	4.11e-05	0.000728	CcSEcCtD
Labetalol—Headache—Bupropion—obesity	4.11e-05	0.000728	CcSEcCtD
Labetalol—Hyperhidrosis—Topiramate—obesity	4.04e-05	0.000715	CcSEcCtD
Labetalol—Hypotension—Topiramate—obesity	3.9e-05	0.000692	CcSEcCtD
Labetalol—Nausea—Bupropion—obesity	3.89e-05	0.00069	CcSEcCtD
Labetalol—Propafenone—ADRB1—obesity	3.75e-05	0.0172	CrCbGaD
Labetalol—Paraesthesia—Topiramate—obesity	3.75e-05	0.000665	CcSEcCtD
Labetalol—Dyspnoea—Topiramate—obesity	3.72e-05	0.00066	CcSEcCtD
Labetalol—Somnolence—Topiramate—obesity	3.71e-05	0.000658	CcSEcCtD
Labetalol—Dyspepsia—Topiramate—obesity	3.68e-05	0.000651	CcSEcCtD
Labetalol—Isoprenaline—ADRB1—obesity	3.61e-05	0.0165	CrCbGaD
Labetalol—Fatigue—Topiramate—obesity	3.6e-05	0.000638	CcSEcCtD
Labetalol—Constipation—Topiramate—obesity	3.57e-05	0.000633	CcSEcCtD
Labetalol—Pain—Topiramate—obesity	3.57e-05	0.000633	CcSEcCtD
Labetalol—Feeling abnormal—Topiramate—obesity	3.44e-05	0.00061	CcSEcCtD
Labetalol—Gastrointestinal pain—Topiramate—obesity	3.41e-05	0.000605	CcSEcCtD
Labetalol—Mirabegron—ALB—obesity	3.37e-05	0.0154	CrCbGaD
Labetalol—Urticaria—Topiramate—obesity	3.32e-05	0.000588	CcSEcCtD
Labetalol—Abdominal pain—Topiramate—obesity	3.3e-05	0.000585	CcSEcCtD
Labetalol—Body temperature increased—Topiramate—obesity	3.3e-05	0.000585	CcSEcCtD
Labetalol—Hypersensitivity—Topiramate—obesity	3.08e-05	0.000545	CcSEcCtD
Labetalol—Isoprenaline—ADRB2—obesity	3.04e-05	0.0139	CrCbGaD
Labetalol—Asthenia—Topiramate—obesity	3e-05	0.000531	CcSEcCtD
Labetalol—Pruritus—Topiramate—obesity	2.95e-05	0.000524	CcSEcCtD
Labetalol—Diarrhoea—Topiramate—obesity	2.86e-05	0.000506	CcSEcCtD
Labetalol—Dizziness—Topiramate—obesity	2.76e-05	0.000489	CcSEcCtD
Labetalol—Salsalate—PTGS2—obesity	2.74e-05	0.0125	CrCbGaD
Labetalol—Vomiting—Topiramate—obesity	2.66e-05	0.000471	CcSEcCtD
Labetalol—Rash—Topiramate—obesity	2.63e-05	0.000467	CcSEcCtD
Labetalol—Dermatitis—Topiramate—obesity	2.63e-05	0.000466	CcSEcCtD
Labetalol—Headache—Topiramate—obesity	2.62e-05	0.000464	CcSEcCtD
Labetalol—Nausea—Topiramate—obesity	2.48e-05	0.00044	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—obesity	2.26e-05	0.0104	CrCbGaD
Labetalol—Fenoprofen—ALB—obesity	2.01e-05	0.00922	CrCbGaD
Labetalol—Flurbiprofen—PTGS2—obesity	1.48e-05	0.00675	CrCbGaD
Labetalol—Ketoprofen—PTGS2—obesity	1.33e-05	0.00611	CrCbGaD
Labetalol—Flurbiprofen—ALB—obesity	1.31e-05	0.00602	CrCbGaD
Labetalol—Ketoprofen—ALB—obesity	1.19e-05	0.00544	CrCbGaD
Labetalol—CYP2D6—Metabolism—PCK1—obesity	4.15e-06	0.00012	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HADH—obesity	4.15e-06	0.00012	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FADS1—obesity	4.15e-06	0.00012	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—F2—obesity	4.14e-06	0.000119	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKCB—obesity	4.14e-06	0.000119	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CNR1—obesity	4.1e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—BAD—obesity	4.09e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—POMC—obesity	4.08e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—F2—obesity	4.07e-06	0.000117	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PRKCB—obesity	4.07e-06	0.000117	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ACP5—obesity	4.04e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TCF7L2—obesity	4.03e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CNR1—obesity	4.01e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT2—obesity	4.01e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD2—obesity	4e-06	0.000115	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CG—obesity	3.98e-06	0.000115	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CG—obesity	3.96e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GCG—obesity	3.96e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTPN1—obesity	3.96e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TCF7L2—obesity	3.94e-06	0.000114	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—G6PD—obesity	3.94e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT2—obesity	3.92e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IRS1—obesity	3.92e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD2—obesity	3.91e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CG—obesity	3.89e-06	0.000112	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HK1—obesity	3.89e-06	0.000112	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SREBF2—obesity	3.89e-06	0.000112	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTPN1—obesity	3.87e-06	0.000112	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GCG—obesity	3.87e-06	0.000112	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	3.85e-06	0.000111	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—POMC—obesity	3.79e-06	0.000109	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRL—obesity	3.78e-06	0.000109	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—POMC—obesity	3.77e-06	0.000109	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	3.77e-06	0.000109	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPA—obesity	3.76e-06	0.000108	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—INS—obesity	3.75e-06	0.000108	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STK11—obesity	3.72e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—obesity	3.71e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—POMC—obesity	3.71e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRL—obesity	3.7e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—obesity	3.69e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLG—obesity	3.68e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—RHOA—obesity	3.68e-06	0.000106	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPIN1—obesity	3.68e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STK11—obesity	3.64e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT2—obesity	3.64e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	3.64e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1—obesity	3.63e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—obesity	3.63e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT2—obesity	3.62e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLG—obesity	3.6e-06	0.000104	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA5—obesity	3.6e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—RHOA—obesity	3.6e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FOXO3—obesity	3.59e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRB2—obesity	3.58e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT2—obesity	3.56e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	3.56e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SOCS1—obesity	3.53e-06	0.000102	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FOXO3—obesity	3.52e-06	0.000101	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CD—obesity	3.5e-06	0.000101	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SOCS3—obesity	3.49e-06	0.0001	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CD—obesity	3.48e-06	0.0001	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SOCS1—obesity	3.45e-06	9.95e-05	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CA—obesity	3.45e-06	9.94e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SERPINE1—obesity	3.44e-06	9.93e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CLOCK—obesity	3.44e-06	9.9e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC22A1—obesity	3.44e-06	9.9e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CD—obesity	3.42e-06	9.86e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GNB3—obesity	3.41e-06	9.84e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SOCS3—obesity	3.41e-06	9.83e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—TYK2—obesity	3.37e-06	9.7e-05	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	3.36e-06	9.68e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF2—obesity	3.35e-06	9.66e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TYK2—obesity	3.35e-06	9.65e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SULT2A1—obesity	3.35e-06	9.65e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GLP1R—obesity	3.35e-06	9.65e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GNB3—obesity	3.34e-06	9.62e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—RHOA—obesity	3.34e-06	9.62e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GNAS—obesity	3.32e-06	9.58e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RHOA—obesity	3.32e-06	9.58e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3R1—obesity	3.3e-06	9.52e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DPYD—obesity	3.29e-06	9.49e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—TYK2—obesity	3.29e-06	9.49e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOS3—obesity	3.29e-06	9.48e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3R1—obesity	3.29e-06	9.48e-05	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	3.28e-06	9.47e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF2—obesity	3.28e-06	9.45e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—RHOA—obesity	3.27e-06	9.41e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOB—obesity	3.25e-06	9.38e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GNAS—obesity	3.25e-06	9.37e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3R1—obesity	3.23e-06	9.31e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOB—obesity	3.18e-06	9.18e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL5—obesity	3.18e-06	9.16e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PRKAR2B—obesity	3.17e-06	9.14e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DCN—obesity	3.15e-06	9.07e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CA—obesity	3.13e-06	9.03e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL5—obesity	3.11e-06	8.96e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LPL—obesity	3.11e-06	8.96e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FOXO1—obesity	3.09e-06	8.89e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RPS6KB1—obesity	3.08e-06	8.88e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CPT1A—obesity	3.06e-06	8.82e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CB—obesity	3.05e-06	8.79e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LPL—obesity	3.04e-06	8.76e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CB—obesity	3.04e-06	8.75e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MTOR—obesity	3.04e-06	8.75e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FOXO1—obesity	3.02e-06	8.7e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RPS6KB1—obesity	3.01e-06	8.68e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NAMPT—obesity	3e-06	8.65e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCK—obesity	2.98e-06	8.6e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LIPC—obesity	2.98e-06	8.6e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CB—obesity	2.98e-06	8.6e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOC3—obesity	2.97e-06	8.55e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CETP—obesity	2.88e-06	8.3e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCD—obesity	2.86e-06	8.25e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SDC1—obesity	2.85e-06	8.2e-05	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—obesity	2.82e-06	8.12e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—obesity	2.8e-06	8.08e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCD—obesity	2.8e-06	8.07e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKR1C3—obesity	2.8e-06	8.07e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—C3—obesity	2.8e-06	8.06e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—obesity	2.77e-06	7.99e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SCARB1—obesity	2.76e-06	7.94e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—obesity	2.74e-06	7.9e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—C3—obesity	2.74e-06	7.89e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SREBF1—obesity	2.68e-06	7.71e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IRS2—obesity	2.66e-06	7.67e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGT—obesity	2.66e-06	7.66e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—obesity	2.64e-06	7.6e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LEP—obesity	2.61e-06	7.51e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—obesity	2.61e-06	7.51e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IRS2—obesity	2.6e-06	7.5e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GOT2—obesity	2.6e-06	7.5e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGT—obesity	2.6e-06	7.5e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CAV1—obesity	2.58e-06	7.44e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOA1—obesity	2.58e-06	7.42e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK8—obesity	2.57e-06	7.39e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—obesity	2.56e-06	7.37e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LEP—obesity	2.55e-06	7.34e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—obesity	2.55e-06	7.34e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FASN—obesity	2.55e-06	7.34e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—BCHE—obesity	2.54e-06	7.31e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CAV1—obesity	2.52e-06	7.28e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOA1—obesity	2.52e-06	7.26e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ESR1—obesity	2.49e-06	7.17e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCB—obesity	2.46e-06	7.08e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—F2—obesity	2.46e-06	7.08e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2E1—obesity	2.45e-06	7.05e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ESR1—obesity	2.43e-06	7.01e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—BAD—obesity	2.43e-06	7e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NQO1—obesity	2.42e-06	6.98e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—F2—obesity	2.4e-06	6.93e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCB—obesity	2.4e-06	6.93e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—BAD—obesity	2.37e-06	6.84e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CG—obesity	2.35e-06	6.78e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STAT3—obesity	2.35e-06	6.76e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IRS1—obesity	2.32e-06	6.7e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC2A4—obesity	2.32e-06	6.69e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCG—obesity	2.32e-06	6.69e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CG—obesity	2.3e-06	6.63e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYCS—obesity	2.29e-06	6.6e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IRS1—obesity	2.27e-06	6.55e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GOT1—obesity	2.25e-06	6.48e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GGT1—obesity	2.25e-06	6.48e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—POMC—obesity	2.24e-06	6.45e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—INS—obesity	2.23e-06	6.41e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NCOA1—obesity	2.21e-06	6.38e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—obesity	2.19e-06	6.31e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—POMC—obesity	2.19e-06	6.31e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—STK11—obesity	2.18e-06	6.29e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP19A1—obesity	2.18e-06	6.29e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MYC—obesity	2.18e-06	6.28e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—INS—obesity	2.18e-06	6.27e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—obesity	2.17e-06	6.27e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1—obesity	2.15e-06	6.2e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT2—obesity	2.15e-06	6.2e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—obesity	2.14e-06	6.17e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1—obesity	2.11e-06	6.07e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT2—obesity	2.1e-06	6.06e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CD—obesity	2.07e-06	5.96e-05	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	2.05e-06	5.9e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SERPINE1—obesity	2.04e-06	5.89e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—COMT—obesity	2.03e-06	5.85e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CD—obesity	2.02e-06	5.83e-05	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	2e-06	5.77e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GNB3—obesity	2e-06	5.76e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARGC1A—obesity	2e-06	5.76e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SERPINE1—obesity	2e-06	5.76e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—obesity	1.99e-06	5.74e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TYK2—obesity	1.99e-06	5.73e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RHOA—obesity	1.97e-06	5.68e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOS3—obesity	1.95e-06	5.62e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3R1—obesity	1.95e-06	5.62e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GNAS—obesity	1.95e-06	5.61e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TYK2—obesity	1.94e-06	5.61e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RHOA—obesity	1.93e-06	5.56e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3R1—obesity	1.91e-06	5.5e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOS3—obesity	1.91e-06	5.5e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOB—obesity	1.91e-06	5.5e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CA—obesity	1.86e-06	5.36e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CA—obesity	1.85e-06	5.33e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPL—obesity	1.82e-06	5.25e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CA—obesity	1.82e-06	5.24e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CB—obesity	1.8e-06	5.19e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MTOR—obesity	1.8e-06	5.19e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—obesity	1.78e-06	5.12e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MTOR—obesity	1.76e-06	5.08e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CB—obesity	1.76e-06	5.08e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CD36—obesity	1.73e-06	4.99e-05	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—obesity	1.67e-06	4.82e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—obesity	1.65e-06	4.74e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—obesity	1.64e-06	4.72e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—obesity	1.64e-06	4.72e-05	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—obesity	1.64e-06	4.71e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—obesity	1.61e-06	4.64e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARA—obesity	1.61e-06	4.64e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—obesity	1.57e-06	4.51e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AGT—obesity	1.56e-06	4.49e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—obesity	1.53e-06	4.41e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—obesity	1.53e-06	4.4e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK8—obesity	1.52e-06	4.39e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—obesity	1.52e-06	4.38e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAV1—obesity	1.51e-06	4.36e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—obesity	1.51e-06	4.36e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA1—obesity	1.51e-06	4.35e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK8—obesity	1.49e-06	4.29e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—obesity	1.49e-06	4.28e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT3—obesity	1.39e-06	4.01e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CG—obesity	1.38e-06	3.97e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT3—obesity	1.36e-06	3.92e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—obesity	1.33e-06	3.83e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—POMC—obesity	1.31e-06	3.78e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—INS—obesity	1.3e-06	3.76e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MYC—obesity	1.29e-06	3.73e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—obesity	1.29e-06	3.72e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MYC—obesity	1.27e-06	3.65e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—obesity	1.26e-06	3.64e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CD—obesity	1.21e-06	3.49e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—obesity	1.2e-06	3.44e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3R1—obesity	1.14e-06	3.3e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NOS3—obesity	1.14e-06	3.3e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CA—obesity	1.1e-06	3.16e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CA—obesity	1.07e-06	3.1e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CB—obesity	1.06e-06	3.04e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—obesity	1.05e-06	3.01e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—obesity	9.72e-07	2.8e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—obesity	9.51e-07	2.74e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—obesity	8.97e-07	2.59e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—obesity	8.78e-07	2.53e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CA—obesity	6.43e-07	1.85e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—obesity	5.26e-07	1.51e-05	CbGpPWpGaD
